COMMUNIQUÉS West-GlobeNewswire

Golden Leaf Holdings Acquires Cultivation License for Bald Peak Facility in Oregon

30/10/2018 - 21:36

PORTLAND, Ore., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]

Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2018 Earnings and Corporate Developments

30/10/2018 - 21:30

CAMBRIDGE, Mass., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]

Osiris Therapeutics, Inc. to Present Advanced Clinical and Scientific Abstracts at Symposium on Advanced Wound Care (SAWC) Fall Meeting, November 2-4, 2018, in Las Vegas, Nevada

30/10/2018 - 21:30

COLUMBIA, Md., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]

Profound Medical to Release Third Quarter 2018 Financial Results on November 8 – Conference Call to Follow

30/10/2018 - 21:30

TORONTO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]

CooperSurgical, Inc. Launches PGTai Technology Platform and ERPeak Endometrial Receptivity Test

30/10/2018 - 21:15

TRUMBULL, Conn., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CooperSurgical, Inc. announced the launch of the CooperGenomics SM PGTai SM technology platform and ERPeak SM endometrial receptivity test at ASRM 2018. The PGTai SM [...]

CymaBay to Report Third Quarter 2018 Financial Results on Tuesday, November 6

30/10/2018 - 21:05

NEWARK, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Prothena to Report Third Quarter 2018 Financial Results on November 6

30/10/2018 - 21:05

DUBLIN, Ireland, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the third quarter and first nine months of 2018 on [...]

Cutera to Present at Three Upcoming Healthcare Conferences

30/10/2018 - 21:05

BRISBANE, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC., (Nasdaq: CUTR ) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]

BioTelemetry, Inc. Reports Third Quarter 2018 Financial Results

30/10/2018 - 21:05

Company’s Results Exceed Expectations Company Raises Full-Year Guidance MALVERN, Pa., Oct. 30, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company [...]

KemPharm Enters Into License Agreement with KVK Tech for the Commercialization of APADAZ®

30/10/2018 - 21:05

Partnership with KVK, One of the Largest Manufacturers of Controlled Substances in the U.S., Opens the Door for Commercial Launch of APADAZ with PBMs and MCOs KemPharm to Host a Conference Call Today, Tuesday, October [...]

electroCore, Inc. to Report Third Quarter Financial Results on November 13, 2018

30/10/2018 - 21:05

BASKING RIDGE, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it will release financial results for the [...]

Myriad Genetics to Present at the Stephens New York Investment Conference

30/10/2018 - 21:05

SALT LAKE CITY, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that R. Bryan Riggsbee, CFO, is scheduled to present [...]

CytomX Therapeutics to Announce Third Quarter 2018 Financial Results

30/10/2018 - 21:03

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]

Cara Therapeutics to Announce Third Quarter 2018 Financial Results on November 6, 2018

30/10/2018 - 21:01

STAMFORD, Conn., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results and Provide Corporate Update

30/10/2018 - 21:01

BURNABY, British Columbia, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it will report its third quarter 2018 financial and [...]

Aduro Biotech Reports Third Quarter 2018 Financial Results

30/10/2018 - 21:01

BERKELEY, Calif., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today reported financial results for the third quarter ended September 30, 2018. Net loss for the third quarter of 2018 was $23.1 [...]

Cerecor Receives Rare Pediatric Disease Designation for CERC-801 for Patients with Inborn Error of Metabolism

30/10/2018 - 21:00

BALTIMORE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]

Changes in Clocks and Amount of Light Affect Sleep and Health - Tips from a Sleep Physician to Successfully Deal with Fall’s Time Change and Reduced Daylight Hours

30/10/2018 - 20:12

CALGARY, Alberta, Oct. 30, 2018 (GLOBE NEWSWIRE) -- The clocks go back an hour at 02:00 AM Sunday morning, providing an extra hour of much needed sleep. “As many as 30 per cent of people in society are chronically sleep [...]

OSE Immunotherapeutics Presents Selective SIRP-alpha antibodies: OSE-172, a next-generation myeloid checkpoint inhibitor at the World Immunotherapy Congress

30/10/2018 - 18:00

Basel, Oct. 29-31, 2018 NANTES, France, Oct. 30, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) presented at the World Immunotherapy Congress held on Oct. 29-31, 2018 in Basel, [...]